Pharmacyclics, Inc. (PCYC) Blows Up Q2 Views, Posts Surprise Profit
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Total revenues: 205.77M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Financial Fact:
Total revenues: 205.77M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of $0.82, $1.00 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $77.9 million versus the consensus estimate of $2.64 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- JD.com (JD) Tops Q1 EPS by 66c
- Pluralsight (PS) Reports Q2 EPS of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
